


Inthelia Therapeutics Revenue
Biotechnology Research • Dublin, Co Dublin, Ireland • 1-10 Employees
Inthelia Therapeutics revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Key Contact at Inthelia Therapeutics
Ivan Coulter
Co-Founder
Company overview
| Headquarters | Dublin, Co Dublin, Ireland |
| Website | |
| NAICS | 541714 |
| Keywords | Sepsis, Barrier Stabilization, Host-Directed Therapy |
| Founded | 2021 |
| Employees | 1-10 |
About Inthelia Therapeutics
Inthelia Therapeutics aims to develop a novel, non-antibiotic approach to treat and prevent severe bloodstream infections. We are a clinical-stage biotechnology research company that target early to intermediate stages of sepsis occurring from bacterial, viral, and fungal infections. Built on unparalleled and leading-edge experimental approaches across the fields of computational, structural, and functional biology, we identify critical pathways used by major human pathogens. We believe we have a unique approach to sepsis therapy by introducing unprecedented host-directed therapeutics to block sepsis in early phases, which circumvents the issue surrounding antimicrobial resistance.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Inthelia Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Inthelia Therapeutics has never raised funding before.
Inthelia Therapeutics Tech Stack
Discover the technologies and tools that power Inthelia Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Security
JavaScript libraries
Analytics
Maps
JavaScript libraries
JavaScript libraries
Miscellaneous
Security
Programming languages
WordPress plugins
Blogs
Frequently asked questions
4.8
40,000 users



